Stocktoria
Metagenomi Therapeutics, Inc. MGX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-09
Metagenomi Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 420,242 | $1.7M |
| RENAISSANCE TECHNOLOGIES LLC | 787,900 | $1.1M |
| TWO SIGMA INVESTMENTS, LP | 496,767 | $665,668 |
| MILLENNIUM MANAGEMENT LLC | 170,104 | $227,939 |
| CITADEL ADVISORS LLC | 16,993 | $22,771 |
| Point72 Asset Management, L.P. | 11,726 | $15,713 |
Source: SEC EDGAR filings · CIK 0001785279 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.